Q3 2023 Pharmacy & Infusion Services Update
In Q3-23, healthcare providers continued expanding upon their home infusion service lines as site-of-care strategies grow in importance. The COVID-19 pandemic increased demand for home-based care, boosting growth in the home infusion therapy sector. Home infusion therapy offers various benefits including convenience, cost-effectiveness, better outcomes, and higher safety standards.Pharmacy services are also shifting towards more home and community-based settings as highlighted by the Tabula and ExactCare Pharmacy merger.
Provident anticipates that deal flow will remain resilient as healthcare systems continue to invest in home and community-based infusion and pharmacy service lines.
To print and download the full Pharmacy & Infusion Services Update report, please click below…
